Section 10400.6 - Anthrone Test for Diagnosis of Cancer(a) As used in this section, the Anthrone test means the determination of the presence or degree of malignancy by the purported determination of the 24 hour level of chorionic gonadotropin excretion in urine as such method is described and defined in the report entitled in part REPORT, FINDINGS AND RECOMMENDATIONS of the CALIFORNIA CANCER ADVISORY COUNCIL with respect to the DIAGNOSIS OF CANCER WITH THE ANTHRONE TEST dated August 17, 1964.(b) Except as otherwise provided in Section 1708 of the Health and Safety Code, the use of the Anthrone test, as described in subsection (a) of this section, or any test substantially similar thereto for the diagnosis of cancer in any patient who has or who believes that he has or who may have cancer is prohibited.(c) No person shall, for the purpose of using the Anthrone test in any guise whatever, make any representation that it has any value in diagnosing cancer.Cal. Code Regs. Tit. 17, § 10400.6
1. New section filed 7-28-65; effective thirtieth day thereafter (Register 65, No. 13).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51). Note: Authority cited: Sections 208 and 1704, Health and Safety Code. Reference: Section 1704, Health and Safety Code.
1. New section filed 7-28-65; effective thirtieth day thereafter (Register 65, No. 13).
2. Amendment filed 12-17-85; effective thirtieth day thereafter (Register 85, No. 51).